Borth W, Dunky A, Kleesiek K
Arthritis Rheum. 1986 Mar;29(3):319-25. doi: 10.1002/art.1780290303.
The levels of alpha1-proteinase inhibitor-elastase and alpha 2-macroglobulin (alpha 2M)-proteinase complexes were measured in synovial fluids from arthritis patients by use of specific immunosorbent assays. Both types of proteinase inhibitor-proteinase complexes were significantly correlated with each other as well as with the total neutrophil count in synovial fluids of rheumatoid arthritis patients but were discordant in synovial fluids of patients with osteoarthritis. One synovial fluid sample showed active (inhibitory) alpha 2M as well as active collagenase. We purified alpha 2M from pooled synovial fluids obtained from patients with rheumatoid arthritis. This alpha 2M retained approximately 90% of its proteinase binding (inhibiting) capacity, compared with that of normal plasma alpha 2M. We found no evidence that alpha 2M was inactivated by means other than proteinases.
采用特异性免疫吸附测定法,对关节炎患者滑液中的α1-蛋白酶抑制剂-弹性蛋白酶和α2-巨球蛋白(α2M)-蛋白酶复合物水平进行了检测。类风湿关节炎患者滑液中,这两种蛋白酶抑制剂-蛋白酶复合物彼此之间以及与总中性粒细胞计数均显著相关,但骨关节炎患者滑液中的情况则不一致。一份滑液样本显示存在活性(抑制性)α2M以及活性胶原酶。我们从类风湿关节炎患者的合并滑液中纯化出α2M。与正常血浆α2M相比,这种α2M保留了约90%的蛋白酶结合(抑制)能力。我们没有发现证据表明α2M会通过蛋白酶以外的其他方式失活。